Anti‐epidermal growth factor receptor monoclonal antibody combined with chemotherapy in penile cancer: A prospective, multicenter, phase 1 study

Documenti analoghi

• Updates on the treatment of epidermal growth factor receptor‐mutant non–small cell lung cancer
  di: Jinyong Kim, et al.
  Pubblicazione: (2025)
• Correction to “G protein pathway suppressor 2 suppresses gastric cancer by destabilizing epidermal growth factor receptor”
  Pubblicazione: (2024)
• Association between exposure to organophosphate flame retardants and epidermal growth factor receptor expression in lung cancer patients
  di: Po‐Ju Chen, et al.
  Pubblicazione: (2024)
• Schizandrin A induces non‐small cell lung cancer apoptosis by suppressing the epidermal growth factor receptor activation
  di: Linhai Zhu, et al.
  Pubblicazione: (2024)
• Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody‐drug conjugates–induced interstitial lung disease/pneumonitis: An expert consensus in China
  di: Chunwei Xu, et al.
  Pubblicazione: (2024)